Market potentials of robotic systems in medical science: analysis of the Avatera robotic system
| Autor: | Iason Kyriazis, Arman Tsaturyan, Panagiotis Kallidonis, Anastasios Magoutas, Evangelos Liatsikos, Dimitris Manolopoulos |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Da Vinci
Business modeling business.industry Urology SWOT analysis Business model Marketing strategy Avatera robotic system Cost reduction Competition (economics) Robotic systems Robotic Surgical Procedures Risk analysis (engineering) Costs and Cost Analysis Cost analysis Humans Robot-assisted surgery Medicine Robot Original Article Robotic surgery business |
| Zdroj: | World Journal of Urology |
| ISSN: | 1433-8726 0724-4983 |
| DOI: | 10.1007/s00345-021-03809-z |
| Popis: | Purpose To evaluate the potential opportunities and possible competitiveness of Avatera robotic system (ARS) (Avateramedical, Germany), and perform predictive cost-analysis for its implementation and dissemination. Material and methods Our study employed a projective quantitative research design. SWOT (strengths, weaknesses, opportunities, threats) analysis was used to map ARS internal competencies towards external contexts, and potential opportunities and risks in the robotic market. The ARS purchase and procedural costs were evaluated in two different scenarios. Results In the first scenario, setting the purchase cost of the Avatera at around $1.3–1.5 million, a total $400 procedural cost reduction compared to the RAS performed with the da Vinci Xi can be calculated. In the second scenario, with a purchase cos of the ARS of $700.000–800.000 and considering a 5-year period with an annual ARS volume of 500 procedures, only an additional $300 will be attributed to the robot itself. Our projections revealed that for an effective competition the purchase cost of ARS should range between $700.000 and $800.000 during the initial phase of market entry. The marketing strategy of the ARS should be oriented towards countries without any robotic system in operational use, followed by countries where the competition intensity in the marketplace is low. Conclusion The introduction of new robotic systems will greatly affect and reshape the market of robotic surgery. The ARS has all the technical capacity ensuring the performance of high-quality surgical procedures. A fast spread and implementation of the ARS could be expected should the purchase and maintenance costs be kept low. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink